If you’ve been reading my daily posts for very long at all, you should be pretty used to seeing me evaluate companies throughout the market on the basis of both their fundamental strength as well as their value proposition. That’s because in the search for good investing opportunities, I’ve learned to rely on a few […]
Read MorePlus, Moody’s downgraded Ford to junk, China’s Huawei dropped a lawsuit against the U.S., WeWork is moving ahead with its IPO, and Wendy’s is bringing back breakfast.
Read MoreTrade Setup Buy Target – $1.75 or better Sell Target – TradersPro Sell Signal Digital Ally, Inc. produces and sells digital video imaging and storage products for use in law enforcement, security, and commercial applications in the United States and internationally. Its digital audio/video recording, storage, and other products include an in-car digital audio/video recorder […]
Read MoreProgress on the trade front has given the market a new set of momentum over the past couple of weeks – enough that the major indices are nearing the all-time highs they set at the end of July. Even so, the unpredictability associated with tariff news and the trade war itself has resulted in a […]
Read MoreNo. 6: Satsuma Pharmaceuticals Inc. (STSA) Satsuma is a San Francisco-based pharmaceutical firm developing a dry-powder nasal spray to treat migraines. The product candidate — STS101 — can be quickly self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company began a Phase 3 electronic medical records and genomics (eMERGE) trial for STS101 this […]
Read MoreTrade Setup Buy Target – $2.70 or better Sell Target – TradersPro Sell Signal Generex Biotechnology Corporation, through its subsidiaries, primarily engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an insulin formulation administered as […]
Read MorePlus, Paul Singer’s Elliott Management just took a new stake in AT&T, Apple will announce new iPhones tomorrow, and shares of Chipotle are climbing.
Read MoreThere are a lot of factors that a smart investor should consider when thinking about using a stock for a long-term investing opportunity. A company’s fundamental strength and relative value are two of the primary elements that I pay attention to, but along with those I also factor in technical factors like the stock’s long-term […]
Read MoreTrade Setup Buy Target – $12.40 or better Sell Target – TradersPro Sell Signal Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C […]
Read MorePlus, the Labor Department’s job’s report, the Trump Administration’s plans to release Fannie Mae and Freddie Mac from federal control, and why shares of Lululemon and DocuSign are surging higher.
Read MoreBuy Target – $31.00 or better Sell Target – TradersPro Sell Signal Federal Signal Corporation, together with its subsidiaries, designs, manufactures, and supplies a suite of products and integrated solutions for municipal, governmental, industrial, and commercial customers in the United States, Canada, Europe, and internationally. It operates through two segments, Environmental Solutions Group and Safety […]
Read MoreI’m wrapping up my run through the Healthcare Equipment industry by looking at a stock that, like just about the entire rest of the industry, is at the extreme high end of a very long-term upward trend. Part of the reason that this industry has drawn my attention this week is because of the extended […]
Read MoreThese 5 stocks had a rough August, but one in the bunch looks like its ready to return to its former glory.
Read More“This fundamental concept is the same one that resulted in the market meltdowns in 2008.” And when this trend reverses, “it will get ugly,” Burry says.
Read MoreMorgan Stanley says these 4 defensive names are buys right now.
Read More